Articles in the press
Poor bioavailability and solubility are key factors in the failure of many small molecule drugs to reach the market. To alleviate these challenges, drug developers are increasingly turning to specialist formulation partners to leverage their expertise in bioavailability- and solubility-enhancing techniques. Special feature published in DRUG DEVELOPMENT & DELIVERY.
HERMES PHARMA’s innovative user-friendly dosage form, HERMES NutriCaps, means food supplements can now be prepared as pleasant-tasting hot drinks using home Nespresso® coffee machines, offering consumers greater choice and a more enjoyable experience. Article published in WELLNESS, FOODS & SUPPLEMENTS.
Modern consumers expect choice and convenience in almost every part of their lives. But when it comes to taking food supplements, most products are offered as traditional tablets and capsules — dosage forms that many people dislike. HERMES NutriCaps are a new approach to delivering food supplements. Article published in NUTRACEUTICAL BUSINESS REVIEW.
Niki Cutler, Innovation and Trends Editor at NutraIngredients.com, spoke to HERMES PHARMA's Detlev Haack about trends in nutraceuticals and HERMES NutriCaps, which is a novel format to deliver food supplements.
Outsourcing Formulation Development and Manufacturing: CDMOs Shift to Offer More Specialized Services
Consumers increasingly expect their medicines and supplements to be easy to use and convenient to take. To create innovative, user-friendly pharmaceutical and nutraceutical products for the modern market, developers are increasingly turning to CDMOs with highly specialized formulation development and process technology capabilities. Special feature published by Cindy Dubin in DRUG DEVELOPMENT & DELIVERY.
Designing products that cater to the needs of those who use them seems logical for any competitive market. Yet tablets and capsules, which cause problems for large numbers of patients, remain the default approach for many pharmaceutical companies. It’s time to take a patient-centric approach to pharmaceutical product design. "In My View" by Dr. Thomas Hein, published in THE MEDICINE MAKER.
Because of the unpleasant taste of many APIs, developers use taste-masking technologies and/or flavoring excipients to create products that are well received by patients and consumers. Human taste testing panels suffer from a number of practical and ethical limitations. An alternative approach is the use of electronic tongues. Interview with Dr. Detlev Haack and Dr. Martin Koeberle, published by Tim Wright in CONTRACT PHARMA.
When creating products that need to deliver the API over an extended period of time, many formulations can be cost-prohibitive or inconvenient for consumers to take. HERMES PHARMA’s Dr. Martin Koeberle considers the challenges associated with developing extended release products, and looks at user-friendly formulations offering an ideal solution. Article published in PHARMACEUTICAL TECHNOLOGY